
Chemical and Pharmaceutical Bulletin p. 623 - 630 (1998)
Update date:2022-09-26
Topics:
Tsuruoka, Akihiko
Kaku, Yumiko
Kakinuma, Hiroyuki
Tsukada, Itaru
Yanagisawa, Manabu
Nara, Kazumasa
Naito, Toshihiko
A series of novel thiazole-containing triazole antifungals was synthesized and evaluated for antifungal activity against a variety of clinically isolated pathogenic fungi in vitro and against systemic candidosis in vivo. These compounds showed potent antifungal activities in vitro and in vivo. In particular, (2R,3R)-3-[4-(4-cyanophenyl)thiazol-2-yl]-2-(2,4- difluorophenyl)-1-(1H-1,2,4-triazol-l-yl)-2-butanol (12g; ER-30346) showed potent and well-balanced in vitro activities and potent in vivo efficacy, and had a good safety profile.
View MoreTAIZHOU XINGCHENG CHEMPHARM CO.,LTD.
Contact:0086-0576-88551200,88886292 ,88880039
Address:B Area. 10 Floor.Yaodadasha. 289#.Shifu Road.Taizhou.Zhejiang.China
Tai zhou world Pharm & Chem Co., Ltd
Contact:+86-576-85301198
Address:Rome 1001,wangjiang plaza,unti 2,jinshan east Road linhai,zhejiang,china
Contact:+1 (647) 918 5848
Address:2343 BRIMLEY RD., Suite 250
CGeneTech (Suzhou, China) Co., Ltd.
Contact:+86-512-62956962
Address:Room 101,Bld C11,218 Xinghu Rd.,Suzhou industrial Park
website:http://www.np-chem.com
Contact:0086-25-52346877
Address:199, Jian Ye Road, Nanjing, China
Doi:10.1007/BF02494546
(1999)Doi:10.1021/ja111474v
(2011)Doi:10.1007/s10593-011-0681-8
(2011)Doi:10.1016/j.poly.2011.02.023
(2011)Doi:10.1002/cmdc.201000546
(2011)Doi:10.1016/j.ultsonch.2012.01.005
(2012)